Marie-Louise Fjaellskog
Director/Board Member bij FARON PHARMACEUTICALS OY
Profiel
Marie-Louise Fjaellskog is currently a Non-Executive Director at Faron Pharmaceuticals Oy and a Director at Lytix Biopharma AS.
She also holds the position of Director at Biovica International AB since 2020 and has been an Associate Professor at the University of Uppsala since 2008.
Previously, she served as Vice President-Clinical Development at Infinity Pharmaceuticals, Inc. from 2018 to 2019 and at Merus NV from 2019 to 2020.
She also worked as the Chief Medical Officer at Sensei Biotherapeutics, Inc. Dr. Fjaellskog holds a doctorate degree from the University of Uppsala.
Actieve functies van Marie-Louise Fjaellskog
Bedrijven | Functie | Begin |
---|---|---|
FARON PHARMACEUTICALS OY | Director/Board Member | 22-09-2023 |
BIOVICA INTERNATIONAL AB | Director/Board Member | 01-01-2020 |
LYTIX BIOPHARMA | Director/Board Member | - |
University of Uppsala | Corporate Officer/Principal | 01-12-2008 |
Eerdere bekende functies van Marie-Louise Fjaellskog
Bedrijven | Functie | Einde |
---|---|---|
MERUS N.V. | Chief Tech/Sci/R&D Officer | 01-06-2020 |
INFINITY PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-04-2019 |
SENSEI BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Marie-Louise Fjaellskog
University of Uppsala | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 6 |
---|---|
INFINITY PHARMACEUTICALS, INC. | Health Technology |
FARON PHARMACEUTICALS OY | Health Technology |
MERUS N.V. | Health Technology |
LYTIX BIOPHARMA | Health Technology |
BIOVICA INTERNATIONAL AB | Health Technology |
SENSEI BIOTHERAPEUTICS, INC. | Health Technology |